<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00180401</url>
  </required_header>
  <id_info>
    <org_study_id>Version vom 05.08.2002</org_study_id>
    <nct_id>NCT00180401</nct_id>
  </id_info>
  <brief_title>MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms</brief_title>
  <official_title>MODULA-Study: Modul 10: Benefit of CRT-therapy in CRT-Patients With QRS-complex of 120 - 150 ms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Guidant Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the benefit of cardiac resynchronization therapy
      (CRT)-therapy in patients with a QRS-complex of 120-150 ms to patients with a QRS-complex of
      &gt; 150 ms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to compare the benefit of CRT-therapy in patients with a
      QRS-complex of 120-150 ms to patients with a QRS-complex of &gt; 150 ms within 12 months. A
      benefit is defined as change in quality of life and change in physical ability.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    no longer interest from medical community
  </why_stopped>
  <start_date>June 2002</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Observational: Benefit of CRT</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>QRS 120-150 ms</arm_group_label>
    <description>Subjects with a QRS width between 120-150 ms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>QRS &gt;150 ms</arm_group_label>
    <description>Subjects with a QRS width &gt;150 ms</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CRT-P and CRT-D devices</intervention_name>
    <arm_group_label>QRS 120-150 ms</arm_group_label>
    <arm_group_label>QRS &gt;150 ms</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with cardiac resynchronization therapy with a defibrillator (CRT-D) or
             cardiac resynchronization therapy pacemakers (CRT-P) system

          -  New York Heart Association (NYHA) III

          -  Ejection fraction (EF) below 35%

          -  Optimised medical therapy

          -  QRS-complex above 120 ms

        Exclusion Criteria:

          -  Patients with CRT-P and atrial fibrillation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Tiroke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum der Christian Albrecht Universität / Kardiologische Abteilung / Arnold Heller-Str. 7 / 24105 Kiel / Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum der Christian Albrecht Universität / Kardiologische Abteilung</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>February 17, 2017</last_update_submitted>
  <last_update_submitted_qc>February 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

